头孢哌酮舒巴坦钠、利巴韦林治疗小儿支气管炎的疗效观察

Efficacy of cefoperazone sulbactam sodium, ribavirin treatment of children with bronchitis

目的探讨头孢哌酮舒巴坦钠、利巴韦林治疗小儿支气管炎的临床效果。方法选取2010年1月～2012年1月在我院就诊的小儿支气管炎患儿60例，随机分为观察组（30例，予以头孢哌酮舒巴坦钠、利巴韦林）和对照组（30例，予以常规治疗）。对比两组患者的疗效及治疗后的喘憋消失时间、喘鸣音消失时间。结果观察组的总有效率达100％，明显高于对照组（P〈0．05）。且观察组患儿治疗后喘憋消失时间（4．15±0．68）d、喘鸣音消失时间（5．21±0．23）d，均分别低于对照组[（7．23±0．46）d、（8．24±0．74）d]，差异具有统计学意义（P〈0．05）。结论头孢哌酮舒巴坦钠、利巴韦林二者联合应用治疗小儿支气管炎疗效好，副作用少，值得推广和应用。

Objective To explore the clinical effect of cefoperazone sulbactam sodium and ribavirin in the treatment of bronchitis in children. Methods Selected 60 cases of children with bronchiolitis in children in our hospital from Jan- uary 2010 to January 2012,were randomly divided into observation group （30 cases,be cefoperazone sulbactam sodi- um, ribavirin） and control group （30 cases,conventional treatment）. The efficacy of the two groups of patients and treatment of wheezing disappeared, wheezing disappeared time were compared. Results The total effective rate of the observation group was 100% ,was significantly higher than the control group （P 〈 0.05）.And observation of the treat- ment of the group of children with wheezing disappeared time of （4.15±0.68） d,wheezing sounds disappear time of （5.21±0.23） d, were significantly lower than the control group[（7.23±0.46） d, （8.24±0.74） d] with a statistically signifi- cant difference. Conclusion Cefoperazone sulbactam sodium, both ribavirin in combination treatment of children with bronchitis, less side effects, worthy of promotion and application